CARMAT Stock price

Equities

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris 12:35:14 2024-03-28 pm EDT 5-day change 1st Jan Change
4.115 EUR +2.11% Intraday chart for CARMAT +6.61% -38.58%
Sales 2023 * 8.64M 9.31M Sales 2024 * 16.41M 17.67M Capitalization 102M 110M
Net income 2023 * -50M -53.86M Net income 2024 * -34M -36.62M EV / Sales 2023 * 17.4 x
Net Debt 2023 * 48.4M 52.13M Net Debt 2024 * 68.9M 74.22M EV / Sales 2024 * 10.4 x
P/E ratio 2023 *
-1.92 x
P/E ratio 2024 *
-3.49 x
Employees 177
Yield 2023 *
-
Yield 2024 *
-
Free-Float 85.45%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on CARMAT

1 day+2.11%
1 week+6.61%
Current month+1.86%
1 month+0.37%
3 months-35.09%
6 months-2.95%
Current year-38.58%
More quotes
1 week
3.87
Extreme 3.87
4.40
1 month
3.66
Extreme 3.66
4.40
Current year
3.66
Extreme 3.66
7.72
1 year
3.00
Extreme 3
9.99
3 years
3.00
Extreme 3
31.70
5 years
3.00
Extreme 3
36.00
10 years
3.00
Extreme 3
96.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 16-08-31
Founder 91 08-06-24
Director of Finance/CFO - 18-12-11
Members of the board TitleAgeSince
Chairman 61 22-12-21
Director/Board Member 85 16-04-11
Director/Board Member 69 18-04-04
More insiders
Date Price Change Volume
24-03-28 4.115 +2.11% 49,786
24-03-27 4.03 +1.51% 21,106
24-03-26 3.97 +0.51% 42,981
24-03-25 3.95 +2.46% 148,131
24-03-22 3.855 -0.13% 22,235

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.115 EUR
Average target price
14.22 EUR
Spread / Average Target
+245.57%
Consensus
  1. Stock
  2. Equities
  3. Stock CARMAT - Euronext Paris